We aim to elucidate how GLP-1 participates in the early stages of taste perception, the molecular and neural mechanisms underlying this process, and its broader implications for understanding the pathophysiology of obesity and the therapeutic effects of GLP-1RAs
SUSTAIN-3, 4, 7, and the Seino study were open-label RCTs
Unfortunately, prolonged usage amplifies the risk of encountering adverse effects
Research shows that Semaglutide typically results in faster and more pronounced weight loss than Sermorelin, making it ideal for those seeking immediate results
GLP-1 can act on the central GLP-1 receptors (especially the hypothalamus) and the central satiety center, causing a feeling of satiety and reducing food intake, thus achieving weight loss through appetite suppression